Questions a plan sponsor actually asks.
What is Estradiol and Norethindrone Acetate Transdermal System used for?
Estradiol and Norethindrone Acetate Transdermal System supplements estrogen levels, used in hormone replacement therapy and contraception.
Is there a generic for Estradiol and Norethindrone Acetate Transdermal System?
No. Estradiol and Norethindrone Acetate Transdermal System is brand-only with no generic equivalents currently in market.
How much does my plan pay for Estradiol and Norethindrone Acetate Transdermal System?
Across 329 Part D plans, Estradiol and Norethindrone Acetate Transdermal System averages $31.83/unit (NADAC). Lowest available: $31.82/unit. Highest in distribution: $31.84/unit.
Is Estradiol and Norethindrone Acetate Transdermal System on the FDA shortage list?
No. Estradiol and Norethindrone Acetate Transdermal System is not currently on the FDA Drug Shortage Database.
5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (2 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.